Cheri’s primary focus is to foster stronger, more productive relationships between Sponsors, CROs, and research sites. Her ability to 'speak the language' of both sides enables her to bridge gaps, facilitate smoother collaborations, anticipate potential issues, propose innovative solutions, and ultimately contribute to more efficient and effective clinical trials. Her commitment to improving site-CRO-sponsor relationships exemplifies Parexel’s dedication to advancing clinical research through collaboration and mutual understanding.